Research map: Prognostic value of HALP score in non-small cell lung cancer (NSCLC) patients with first-line chemotherapy combined with immunotherapy: a real-world retrospective study

Back to the article

Papers in this map

  1. Cancer statistics, 2022 · Rebecca L. Siegel · 2022 · 18359 citations · Cited by this paper
  2. Promising results amid persistent disparities in real-world adherence to multitarget stool DNA testing · 2026 · Related
  3. Cancer Statistics, 2021 · Rebecca L. Siegel · 2021 · 17451 citations · Cited by this paper
  4. Original Abstracts from the 22nd Annual Meeting of ISMPP · 2026 · Related
  5. Cancer statistics, 2023 · Rebecca L. Siegel · 2023 · 17047 citations · Cited by this paper
  6. Real-world comparison of androgen receptor pathway ınhibitors versus docetaxel as first-line treatment in metastatic hormone-sensitive prostate cancer · 2026 · Related
  7. Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer · H. Borghaei · 2015 · 9564 citations · Cited by this paper
  8. Quantifying US healthcare provider preferences for the treatment of post-transplant cytomegalovirus infection using a discrete choice experiment · 2026 · Related
  9. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer · Julie Renee Brahmer · 2015 · 8636 citations · Cited by this paper
  10. Serum calcium and liver injury in people living with HIV: a longitudinal cohort study in Southeast China · 2026 · Related
  11. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial · Roy S. Herbst · 2015 · 6592 citations · Cited by this paper
  12. A novel hypothesis for stroke prediction, introducing CHA 2 DS 2 -VAScF · 2026 · Related
  13. Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship · Julian R. Molina · 2008 · 3106 citations · Cited by this paper
  14. Seizing the opportune moment: early use of antiplatelet therapy for thrombolysis · 2026 · Related
  15. Lung Cancer 2020 · Brett C. Bade · 2020 · 1967 citations · Cited by this paper
  16. Tirzepatide compared with semaglutide in obesity disease: a subpopulation analysis applying Japan Society for the Study of Obesity criteria in the global SURMOUNT-5 trial · 2026 · Related
  17. Relationship of Nutritional Status, Inflammation, and Serum Albumin Levels During Acute Illness: A Prospective Study · Andreas Eckart · 2019 · 749 citations · Cited by this paper
  18. Original Abstracts from the 2026 European Meeting of ISMPP · 2026 · Related
  19. CD4 and CD8 T lymphocyte interplay in controlling tumor growth · Dmitrij Ostroumov · 2017 · 573 citations · Cited by this paper
  20. Adverse effect profile of amphotericin B deoxycholate administered with a standardized infusion protocol in hematologic patients: a prospective study in a resource-limited setting · 2026 · Related
  21. Inflammation-Related Biomarkers for the Prediction of Prognosis in Colorectal Cancer Patients · Takehito Yamamoto · 2021 · 468 citations · Cited by this paper
  22. Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study · Xiao‐Long Chen · 2015 · 333 citations · Cited by this paper
  23. Platelets, Thrombo-Inflammation, and Cancer: Collaborating With the Enemy · Ana-Luisa Palacios-Acedo · 2019 · 286 citations · Cited by this paper
  24. What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types · Christian Mark Farag · 2023 · 211 citations · Cited by this paper
  25. Preoperative combined hemoglobin, albumin, lymphocyte and platelet levels predict survival in patients with locally advanced colorectal cancer · Huihong Jiang · 2016 · 148 citations · Cited by this paper
  26. Prognostic significance of HALP (hemoglobin, albumin, lymphocyte and platelet) in patients with bladder cancer after radical cystectomy · Peng Ding · 2018 · 139 citations · Cited by this paper
  27. The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score in Patients with Small Cell Lung Cancer Before First-Line Treatment with Etoposide and Progression-Free Survival · Xia‐Bo Shen · 2019 · 100 citations · Cited by this paper
  28. Predictive value of the hemoglobin, albumin, lymphocyte, and platelet (HALP) score and lymphocyte-to-monocyte ratio (LMR) in patients with non-small cell lung cancer after radical lung cancer surgery · Baoqian Zhai · 2021 · 79 citations · Cited by this paper
  29. Risk Score Generated from CT-Based Radiomics Signatures for Overall Survival Prediction in Non-Small Cell Lung Cancer · Viet-Huan Le · 2021 · 68 citations · Cited by this paper
  30. Clinical implications of positive margins following non‐small cell lung cancer surgery · Jarrod D. Predina · 2015 · 48 citations · Cited by this paper
  31. One-Year Mortality in Patients with Cancer Cachexia: Association with Albumin and Total Protein · Xiaoyue Liu · 2021 · 43 citations · Cited by this paper
  32. Significance of Pretreatment C-Reactive Protein, Albumin, and C-Reactive Protein to Albumin Ratio in Predicting Poor Prognosis in Epithelial Ovarian Cancer Patients · Naoko Komura · 2020 · 35 citations · Cited by this paper
  33. Low Preoperative Albumin-to-Globulin Ratio Is a Marker of Poor Prognosis in Patients With Esophageal Cancer · Yosuke Atsumi · 2021 · 33 citations · Cited by this paper
  34. Deep Learning Radiomics for Survival Prediction in Non-Small-Cell Lung Cancer Patients from CT Images · Viet Huan Le · 2025 · 29 citations · Cited by this paper
  35. The preoperative hemoglobin, albumin, lymphocyte, and platelet score is a prognostic factor for non-small cell lung cancer patients undergoing adjuvant chemotherapy: a retrospective study · Sheng Wei · 2022 · 27 citations · Cited by this paper
  36. Hemoglobin, albumin, lymphocyte and platelet (HALP) score can predict the prognosis of patients with non-small cell lung cancer (NSCLC) · Binsheng Zhao · 2023 · 19 citations · Cited by this paper
  37. The preoperative hemoglobin, albumin, lymphocyte, and platelet score (HALP) as a prognostic indicator in patients with non-small cell lung cancer · Qiteng Liu · 2024 · 18 citations · Cited by this paper
  38. Osimertinib Should be the Standard of Care for the Adjuvant Therapy of Stage IB to IIIA EGFR-Mutant NSCLC · Jordi Remón · 2021 · 9 citations · Cited by this paper
  39. Correlation of hemoglobin, albumin, lymphocyte, and platelet score with prognosis in patients with stage III squamous lung cancer · Jing-Chen Huo · 2024 · 8 citations · Cited by this paper

Source: OpenAlex (CC0)